Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses.
Napolitano V, Dabrowska A, Schorpp K, Mourão A, Barreto-Duran E, Benedyk M, Botwina P, Brandner S, Bostock M, Chykunova Y, Czarna A, Dubin G, Fröhlich T, Hölscher M, Jedrysik M, Matsuda A, Owczarek K, Pachota M, Plettenburg O, Potempa J, Rothenaigner I, Schlauderer F, Slysz K, Szczepanski A, Greve-Isdahl Mohn K, Blomberg B, Sattler M, Hadian K, Popowicz GM, Pyrc K. Napolitano V, et al. Among authors: holscher m. Cell Chem Biol. 2022 May 19;29(5):774-784.e8. doi: 10.1016/j.chembiol.2021.11.006. Epub 2022 Jan 11. Cell Chem Biol. 2022. PMID: 35021060 Free PMC article.
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial.
Kremsner PG, Mann P, Kroidl A, Leroux-Roels I, Schindler C, Gabor JJ, Schunk M, Leroux-Roels G, Bosch JJ, Fendel R, Kreidenweiss A, Velavan TP, Fotin-Mleczek M, Mueller SO, Quintini G, Schönborn-Kellenberger O, Vahrenhorst D, Verstraeten T, Alves de Mesquita M, Walz L, Wolz OO, Oostvogels L; CV-NCOV-001 Study Group. Kremsner PG, et al. Wien Klin Wochenschr. 2021 Sep;133(17-18):931-941. doi: 10.1007/s00508-021-01922-y. Epub 2021 Aug 10. Wien Klin Wochenschr. 2021. PMID: 34378087 Free PMC article. Clinical Trial.
Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting.
Glasmeyer L, Mcharo RD, Torres L, Lennemann T, Danstan E, Mwinuka N, Judick M, Mueller W, Mbuya W, Hölscher M, Lellé R, Geldmacher C, Kroidl A, France JR. Glasmeyer L, et al. Among authors: holscher m. BMC Cancer. 2022 Aug 15;22(1):892. doi: 10.1186/s12885-022-09966-7. BMC Cancer. 2022. PMID: 35971100 Free PMC article.
Depletion and activation of mucosal CD4 T cells in HIV infected women with HPV-associated lesions of the cervix uteri.
Mbuya W, Mcharo R, Mhizde J, Mnkai J, Mahenge A, Mwakatima M, Mwalongo W, Chiwerengo N, Hölscher M, Lennemann T, Saathoff E, Rwegoshora F, Torres L, Kroidl A, Geldmacher C, Held K, Chachage M. Mbuya W, et al. Among authors: holscher m. PLoS One. 2020 Oct 2;15(10):e0240154. doi: 10.1371/journal.pone.0240154. eCollection 2020. PLoS One. 2020. PMID: 33007050 Free PMC article.
[Secondary surgical interventions in ovarian cancer].
Jänicke F, Kuhn W, Hölscher M, Graeff H. Jänicke F, et al. Among authors: holscher m. Gynakol Rundsch. 1991;31 Suppl 2:26-34. Gynakol Rundsch. 1991. PMID: 1790947 Review. German. No abstract available.
[Developments in the therapy of advanced FIGO III ovarian cancer].
Kuhn W, Jänicke F, Pache L, Hölscher M, Schattenmann G, Schmalfeldt B, Anderl H, Schüle G, Dettmar P, Siewert JR, et al. Kuhn W, et al. Among authors: holscher m. Geburtshilfe Frauenheilkd. 1993 May;53(5):293-302. doi: 10.1055/s-2007-1022886. Geburtshilfe Frauenheilkd. 1993. PMID: 8514099 German.
153 results